Miss Hang Su
Research outputs (2)
Economic evaluation of Tislelizumab Versus Chemotherapy as Second Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
Research output: Contribution to journal › Article › peer-review
Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study
Research output: Contribution to journal › Article › peer-review
Prof. activities and awards (1)
Public engagement in health economics: CHEME at the Bangor Science Festival.
Activity: Other › Types of Public engagement and outreach - Festival/Exhibition